John Kwon

Array ( [id] => 142283 [patent_doc_number] => 07687625 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-03-30 [patent_title] => 'Dipeptidyl peptidase inhibitors' [patent_app_type] => utility [patent_app_number] => 10/809637 [patent_app_country] => US [patent_app_date] => 2004-03-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 52045 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/687/07687625.pdf [firstpage_image] =>[orig_patent_app_number] => 10809637 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7265032 [patent_doc_number] => 20040242568 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-02 [patent_title] => 'Dipeptidyl peptidase inhibitors' [patent_app_type] => new [patent_app_number] => 10/809636 [patent_app_country] => US [patent_app_date] => 2004-03-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 52495 [patent_no_of_claims] => 114 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0242/20040242568.pdf [firstpage_image] =>[orig_patent_app_number] => 10809636 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7265030 [patent_doc_number] => 20040242566 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-02 [patent_title] => 'Dipeptidyl peptidase inhibitors' [patent_app_type] => new [patent_app_number] => 10/809638 [patent_app_country] => US [patent_app_date] => 2004-03-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 52378 [patent_no_of_claims] => 49 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0242/20040242566.pdf [firstpage_image] =>[orig_patent_app_number] => 10809638 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 885018 [patent_doc_number] => 07351822 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-04-01 [patent_title] => 'Serine protease inhibitors' [patent_app_type] => utility [patent_app_number] => 10/803157 [patent_app_country] => US [patent_app_date] => 2004-03-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 41188 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/351/07351822.pdf [firstpage_image] =>[orig_patent_app_number] => 10803157 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5242936 [patent_doc_number] => 20070021431 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-01-25 [patent_title] => 'Reverse-turn mimetics and method relating thereto' [patent_app_type] => utility [patent_app_number] => 10/803179 [patent_app_country] => US [patent_app_date] => 2004-03-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 29916 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0021/20070021431.pdf [firstpage_image] =>[orig_patent_app_number] => 10803179 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 494082 [patent_doc_number] => 07211577 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-05-01 [patent_title] => 'Water-soluble phenylpyridazine derivative and medicine containing the same' [patent_app_type] => utility [patent_app_number] => 10/544881 [patent_app_country] => US [patent_app_date] => 2004-03-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 6 [patent_no_of_words] => 68440 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/211/07211577.pdf [firstpage_image] =>[orig_patent_app_number] => 10544881 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7412595 [patent_doc_number] => 20040176591 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-09-09 [patent_title] => 'Novel synthesis and crystallization of peperazine ring-containing compounds' [patent_app_type] => new [patent_app_number] => 10/800918 [patent_app_country] => US [patent_app_date] => 2004-03-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3804 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0176/20040176591.pdf [firstpage_image] =>[orig_patent_app_number] => 10800918 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7410457 [patent_doc_number] => 20040176370 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-09-09 [patent_title] => '3,4-Dihdro-N-[[1-(3-hydroxybutyl)-4-piperidinyl]methyl]-2H-[1,3]oxazino[3,2-a]indole-10-carboxamide as 5-HT(4) receptor antagonist' [patent_app_type] => new [patent_app_number] => 10/801510 [patent_app_country] => US [patent_app_date] => 2004-03-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4502 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0176/20040176370.pdf [firstpage_image] =>[orig_patent_app_number] => 10801510 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 711139 [patent_doc_number] => 07056920 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-06-06 [patent_title] => 'Pyrrolo[1,2-B]pyridazine compounds and their uses' [patent_app_type] => utility [patent_app_number] => 10/799407 [patent_app_country] => US [patent_app_date] => 2004-03-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9190 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/056/07056920.pdf [firstpage_image] =>[orig_patent_app_number] => 10799407 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7122925 [patent_doc_number] => 20050014754 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-01-20 [patent_title] => 'Fused pyrrole compounds' [patent_app_type] => utility [patent_app_number] => 10/799389 [patent_app_country] => US [patent_app_date] => 2004-03-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20723 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0014/20050014754.pdf [firstpage_image] =>[orig_patent_app_number] => 10799389 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7433356 [patent_doc_number] => 20040209887 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-10-21 [patent_title] => 'Pyrrolo[1,2-B]pyridazine compounds and their uses' [patent_app_type] => new [patent_app_number] => 10/799404 [patent_app_country] => US [patent_app_date] => 2004-03-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8794 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0209/20040209887.pdf [firstpage_image] =>[orig_patent_app_number] => 10799404 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 728731 [patent_doc_number] => 07041671 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-05-09 [patent_title] => 'Pyrrolo[1,2-b]pyridazine compounds and their uses' [patent_app_type] => utility [patent_app_number] => 10/799406 [patent_app_country] => US [patent_app_date] => 2004-03-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7214 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/041/07041671.pdf [firstpage_image] =>[orig_patent_app_number] => 10799406 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 837029 [patent_doc_number] => 07393844 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-07-01 [patent_title] => 'Tetrahydropyranyl cyclopentyl heterocyclic amide modulators of chemokine receptor activity' [patent_app_type] => utility [patent_app_number] => 10/550111 [patent_app_country] => US [patent_app_date] => 2004-03-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 34213 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/393/07393844.pdf [firstpage_image] =>[orig_patent_app_number] => 10550111 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 715991 [patent_doc_number] => 07053085 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-05-30 [patent_title] => 'EP4 receptor agonist, compositions and methods thereof' [patent_app_type] => utility [patent_app_number] => 10/797257 [patent_app_country] => US [patent_app_date] => 2004-03-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18671 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/053/07053085.pdf [firstpage_image] =>[orig_patent_app_number] => 10797257 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5760742 [patent_doc_number] => 20060211687 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-09-21 [patent_title] => 'Potassium salt of an hiv integrase inhibitor' [patent_app_type] => utility [patent_app_number] => 10/548781 [patent_app_country] => US [patent_app_date] => 2004-03-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 12606 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0211/20060211687.pdf [firstpage_image] =>[orig_patent_app_number] => 10548781 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 928567 [patent_doc_number] => 07314877 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-01-01 [patent_title] => 'Benzofuran derivative' [patent_app_type] => utility [patent_app_number] => 10/547779 [patent_app_country] => US [patent_app_date] => 2004-03-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 11615 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/314/07314877.pdf [firstpage_image] =>[orig_patent_app_number] => 10547779 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5046595 [patent_doc_number] => 20070265269 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-11-15 [patent_title] => 'Water Soluble Esters of [N-(4-Amino-2-Butynyl)] with Anticancer Activity' [patent_app_type] => utility [patent_app_number] => 10/598563 [patent_app_country] => US [patent_app_date] => 2004-03-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 15759 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0265/20070265269.pdf [firstpage_image] =>[orig_patent_app_number] => 10598563 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7410691 [patent_doc_number] => 20040176386 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-09-09 [patent_title] => 'Compounds' [patent_app_type] => new [patent_app_number] => 10/787813 [patent_app_country] => US [patent_app_date] => 2004-02-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15238 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0176/20040176386.pdf [firstpage_image] =>[orig_patent_app_number] => 10787813 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 895471 [patent_doc_number] => 07342020 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-03-11 [patent_title] => 'Arylpiperazines and their use as metalloproteinase inhibiting agents (MMP)' [patent_app_type] => utility [patent_app_number] => 10/787775 [patent_app_country] => US [patent_app_date] => 2004-02-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21253 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/342/07342020.pdf [firstpage_image] =>[orig_patent_app_number] => 10787775 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7330054 [patent_doc_number] => 20040254189 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-16 [patent_title] => 'Jnk inhibitors' [patent_app_type] => new [patent_app_number] => 10/487283 [patent_app_country] => US [patent_app_date] => 2004-02-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 30177 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 23 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0254/20040254189.pdf [firstpage_image] =>[orig_patent_app_number] => 10487283 [rel_patent_id] =>[rel_patent_doc_number] =>)